Related Experiment Video
Updated: Jul 10, 2026
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Percutaneous aortic valve replacement: new hope for inoperable and high-risk patients
Helen C Routledge1, Thierry Lefevre, Marie-Claude Morice
1Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France.
Insights
Severe aortic stenosis affects many older adults, often barring them from surgery. Percutaneous aortic valves offer a new treatment option for these patients, with ongoing trials to assess wider availability.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Aortic stenosis is the most prevalent valvular heart disease in Western countries, with increasing incidence due to population aging.
- Severe aortic stenosis often leads to significant morbidity and mortality.
- A substantial proportion of patients with severe aortic stenosis are ineligible for conventional valve surgery due to advanced age and comorbidities.
Purpose of the Study:
- To review the development of percutaneous aortic valves as an alternative therapeutic option.
- To discuss the technique, initial outcomes, and current limitations of percutaneous aortic valve procedures.
- To highlight the importance of ongoing clinical trials for establishing the safety and efficacy of this novel therapy.
Main Methods:
- Review of the literature on percutaneous aortic valve technology and clinical application.
- Analysis of initial results from early studies and registries.
- Discussion of the technical aspects and procedural challenges.
- Examination of current limitations and areas for future research.
Main Results:
- Percutaneous aortic valve implantation has emerged as a viable alternative for patients with severe aortic stenosis who are poor surgical candidates.
- Initial results demonstrate the feasibility and potential efficacy of the procedure, although long-term outcomes are still under investigation.
- Ongoing clinical trials are crucial for defining the optimal patient population, procedural techniques, and long-term safety profile.
Conclusions:
- Percutaneous aortic valve replacement represents a significant advancement in the management of severe aortic stenosis, particularly for high-risk patients.
- Further research and robust clinical trial data are essential to fully establish the role and long-term benefits of this innovative therapy.
- The development of percutaneous aortic valves holds promise for improving the quality of life and prognosis for a vulnerable patient group.
Abstract:
Aortic stenosis is the most common valvular heart disease in the Western world and its prevalence is increasing with an aging population. Although medical therapy has little to offer in terms of prognosis or symptomatic relief, at least one-third of patients with severe aortic stenosis are denied valve surgery as a result of age and comorbidities. This review describes the development of the percutaneous aortic valve as an alternative therapy for such patients. The technique, initial results and the current limitations of the procedure are explained alongside the ongoing trials necessary in order that such therapy may eventually be made widely available.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
01:26Mitral Stenosis III: Medical Management
01:27Peripheral Artery Disease III: Interprofessional Care